Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001180963 | SCV001346016 | likely benign | Familial hypercholesterolemia | 2019-09-17 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001280613 | SCV001467832 | likely benign | not specified | 2020-12-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001494727 | SCV001699389 | likely benign | Hypercholesterolemia, autosomal dominant, 3 | 2021-09-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003163413 | SCV003867151 | likely benign | Cardiovascular phenotype | 2022-12-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV001494727 | SCV004845325 | likely benign | Hypercholesterolemia, autosomal dominant, 3 | 2023-09-05 | criteria provided, single submitter | clinical testing |